Use of a B-type natriuretic peptide in evaluating the treatment response of a relapsed lymphoma with cardiac involvement

International Journal of Hematology

Volumn 83, Issue 1, 2006, Pages 44-46

  Lin, Yu Sheng ^a   Chu, Pao Hsien ^a   Kuo, Ming Chung ^a   Jung, Shih Ming ^a   Lim, Kun Eng ^a   Kuo, Chi Tai ^a   Shih, Lee Yung ^a  

^a CHANG GUNG MEMORIAL HOSPITAL   (Taiwan)

Author keywords

B type natriuretic peptide; Cardiac lymphoma

Indexed keywords

BRAIN NATRIURETIC PEPTIDE; CISPLATIN; CYCLOPHOSPHAMIDE; CYTARABINE; DOXORUBICIN; ETOPOSIDE; METHYLPREDNISOLONE; PREDNISOLONE; VINCRISTINE;

ADULT; ARTICLE; B CELL LYMPHOMA; BONE MARROW BIOPSY; CANCER COMBINATION CHEMOTHERAPY; CANCER REGRESSION; CANCER RELAPSE; CASE REPORT; CLINICAL FEATURE; COMPUTER ASSISTED TOMOGRAPHY; DRUG RESPONSE; FEMALE; FOLLOW UP; HEART LYMPHOMA; HEART TUMOR; HUMAN; LABORATORY TEST; LARGE CELL LYMPHOMA; LYMPH NODE BIOPSY; NONHODGKIN LYMPHOMA; PHYSICAL EXAMINATION; PROTEIN DETERMINATION; TREATMENT OUTCOME; TRICUSPID VALVE; TWO DIMENSIONAL ECHOCARDIOGRAPHY;

FEMALE; HEART NEOPLASMS; HEART VALVE DISEASES; HUMANS; LYMPHOMA, B-CELL; LYMPHOMA, LARGE-CELL, DIFFUSE; MIDDLE AGED; MONITORING, PHYSIOLOGIC; NATRIURETIC PEPTIDE, BRAIN; RECURRENCE; TRICUSPID VALVE;

EID: 31644447820     PISSN: 09255710     EISSN: None     Source Type: Journal    
DOI: 10.1532/IJH97.A10502     Document Type: Article

References (15)

1. Levin ER, Gardner DG, Samson WK. Natriuretic peptides. N Engl J Med. 1998;339:321-328.
2. Nakagawa O, Ogawa Y, Itoh H, et al. Rapid transcriptional activation and early mRNA turnover of brain natriuretic peptide in cardiocyte hypertrophy: evidence for brain natriuretic peptide as an "emergency" cardiac hormone against ventricular overload. J Clin Invest. 1995;96:1280-1287.
3. Boomsma F, van den Meiracker AH. Plasma A- and B-type natriuretic peptides: physiology, methodology and clinical use. Cardiovasc Res. 2001;51:442-449.
4. McCullough PA, Nowak RM, McCord J, et al. B-type natriuretic peptide and clinical judgment in emergency diagnosis of heart failure: analysis from Breathing Not Properly (BNP) Multinational Study. Circulation. 2002;106:416-422.
5. Mueller C, Scholer A, Laule-Kilian K, et al. Use of B-type natriuretic peptide in the evaluation and management of acute dyspnea. N Engl J Med. 2004;350:647-654.
6. Maisel AS, Krishnaswamy P, Nowak RM, et al. Rapid measurement of B-type natriuretic peptide in the emergency diagnosis of heart failure. N Engl J Med. 2002;347:161-167.
7. Reynen K. Cardiac myxomas. N Engl J Med. 1995;333:1610-1617.
8. Chu PH, Jung SM, Yeh CS, Yeh TS, Wang CL. Mucin gene expression in cardiac myxoma. Int J Clin Pract. 2004;58:306-309.
9. Chu PH, Jung SM, Wu HH, et al. Apoptosis in primary cardiac tumor. Int J Clin Pract. 2004;58:564-567.
10. Burke A, Virmani R. Tumors of the heart and great vessel. In: Atlas of Tumor Pathology. Fascicle 16, Series 3. Washington, DC: Armed Forces Institute of Pathology; 1996:111-112.
11. Chim CS, Chan ACL, Kwong YL, Liang R. Primary cardiac lymphoma, Am J Hematol. 1997;54:793-783.
12. Daus H, Bay W, Harig S, Schneider O, Feiden W, Schieffer H. Primary lymphoma of the heart: report of a case with histologic diagnosis of transvenously biopsied intracardiac tumor. Ann Hematol. 1998;77:139-141.
13. Mak GS, DeMaria A, Clopton P, Maisel AS. Utility of B-natriuretic peptide in the evaluation of left ventricular diastolic function: comparison with tissue Doppler imaging recordings. Am Heart J. 2004;148:895-902.
14. Alisha D, Bhalla MA, Morrison LK, et al. A prospective study in search of an optimal B-natriuretic peptide level to screen patients for cardiac dysfunction. Am Heart J. 2004;148:518-523.
15. Redfield MM, Rodeheffer RJ, Jacobsen SJ, Mahoney DW, Bailey KR, Burnett JC Jr. Plasma brain natriuretic peptide to detect preclinical ventricular systolic or diastolic dysfunction: a community-based study. Circulation. 2004;109:3176-3181.